NDC 71335-1478

levothyroxine sodium

Levothyroxine Sodium

levothyroxine sodium is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Levothyroxine Sodium.

Product ID71335-1478_3ed8ee08-1e16-4ded-9cdd-1f8f01d102a8
NDC71335-1478
Product TypeHuman Prescription Drug
Proprietary Namelevothyroxine sodium
Generic NameLevothyroxine Sodium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-05-07
Marketing CategoryNDA / NDA
Application NumberNDA021116
Labeler NameBryant Ranch Prepack
Substance NameLEVOTHYROXINE SODIUM
Active Ingredient Strength100 ug/1
Pharm Classesl-Thyroxine [EPC],Thyroxine [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71335-1478-1

100 TABLET in 1 BOTTLE (71335-1478-1)
Marketing Start Date2020-01-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1478-1 [71335147801]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 71335-1478-2 [71335147802]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 71335-1478-6 [71335147806]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 71335-1478-7 [71335147807]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 71335-1478-4 [71335147804]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 71335-1478-8 [71335147808]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 71335-1478-5 [71335147805]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 71335-1478-3 [71335147803]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 71335-1478-9 [71335147809]

levothyroxine sodium TABLET
Marketing CategoryNDA
Application NumberNDA021116
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

Drug Details

Active Ingredients

IngredientStrength
LEVOTHYROXINE SODIUM100 ug/1

OpenFDA Data

SPL SET ID:9e3bffb9-f66e-4c73-befc-e60d769f6610
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 892246
  • 966222

    • Pharmacological Class

    • l-Thyroxine [EPC]
    • Thyroxine [CS]

    NDC Crossover Matching brand name "levothyroxine sodium" or generic name "Levothyroxine Sodium"

    NDCBrand NameGeneric Name
    68071-3021Levothyroxine sodiumLevothyroxine sodium
    68071-4194Levothyroxine sodiumLevothyroxine sodium
    68071-4202Levothyroxine sodiumLevothyroxine sodium
    68071-4714Levothyroxine SodiumLevothyroxine Sodium
    68071-4719Levothyroxine sodiumLevothyroxine sodium
    68071-4709Levothyroxine SodiumLevothyroxine Sodium
    68071-4731Levothyroxine SodiumLevothyroxine Sodium
    68071-4624Levothyroxine sodiumLevothyroxine sodium
    68071-4626Levothyroxine SodiumLevothyroxine Sodium
    68071-4735Levothyroxine SodiumLevothyroxine Sodium
    68071-4625Levothyroxine sodiumLevothyroxine sodium
    68180-971Levothyroxine SodiumLevothyroxine Sodium
    68180-966Levothyroxine SodiumLevothyroxine Sodium
    68180-975Levothyroxine SodiumLevothyroxine Sodium
    68180-969Levothyroxine SodiumLevothyroxine Sodium
    68180-968Levothyroxine SodiumLevothyroxine Sodium
    68180-976Levothyroxine SodiumLevothyroxine Sodium
    68180-965Levothyroxine SodiumLevothyroxine Sodium
    68180-967Levothyroxine SodiumLevothyroxine Sodium
    68180-972Levothyroxine SodiumLevothyroxine Sodium
    68180-974Levothyroxine SodiumLevothyroxine Sodium
    68180-970Levothyroxine SodiumLevothyroxine Sodium
    68180-973Levothyroxine SodiumLevothyroxine Sodium
    68788-7081Levothyroxine sodiumLevothyroxine sodium
    68788-7279Levothyroxine SodiumLevothyroxine Sodium
    68788-6353Levothyroxine sodiumLevothyroxine sodium
    68788-7233Levothyroxine SodiumLevothyroxine Sodium
    68788-7352Levothyroxine SodiumLevothyroxine Sodium
    68788-7026Levothyroxine sodiumLevothyroxine sodium
    68788-9156Levothyroxine SodiumLevothyroxine Sodium
    68788-9163Levothyroxine SodiumLevothyroxine Sodium
    68788-7132Levothyroxine SodiumLevothyroxine Sodium
    68788-7133Levothyroxine SodiumLevothyroxine Sodium
    68788-6359Levothyroxine sodiumLevothyroxine sodium
    68788-9234Levothyroxine sodiumLevothyroxine sodium
    68788-7349Levothyroxine sodiumLevothyroxine sodium
    68788-7232Levothyroxine sodiumLevothyroxine sodium
    68788-7227Levothyroxine SodiumLevothyroxine Sodium
    68788-7348Levothyroxine SodiumLevothyroxine Sodium
    68788-9157Levothyroxine SodiumLevothyroxine Sodium
    68788-9161Levothyroxine SodiumLevothyroxine Sodium
    68788-9160Levothyroxine SodiumLevothyroxine Sodium
    68788-9162Levothyroxine SodiumLevothyroxine Sodium
    68788-9168Levothyroxine SodiumLevothyroxine Sodium
    0527-1345Levothyroxine SodiumLevothyroxine Sodium
    68788-9235Levothyroxine sodiumLevothyroxine sodium
    68788-9437Levothyroxine SodiumLevothyroxine Sodium
    68788-9159Levothyroxine SodiumLevothyroxine Sodium
    0527-1341Levothyroxine SodiumLevothyroxine Sodium
    0527-1344Levothyroxine SodiumLevothyroxine Sodium
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.